相关实验视频

Updated: Jun 23, 2025

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

帕金森病中间歇性缺氧的随机对照试验:研究理由和方案

Jules M Janssen Daalen^1,2, Marjan J Meinders³, Soania Mathur⁴

¹Radboud University Medical Center, Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Center of Expertise for Parkinson & Movement Disorders, Nijmegen, The Netherlands. Jules.M.JanssenDaalen@radboudumc.nl.

|June 22, 2024

概括

这项研究调查了针对帕金森病 (PD) 的家庭间歇性缺氧疗法. 结果将评估安全性,可行性和症状影响,可能为PD患者提供新的治疗方法.

科学领域:

神经学神经学
呼吸系统生理学呼吸系统生理学
神经退行性疾病研究研究

背景情况:

帕金森病 (PD) 目前缺乏修改疾病的治疗方法.
间歇性缺氧暴露显示了PD中短期和长期益处的潜力.
之前的I期试验证实了PD症状的临床间歇性缺氧的安全性和可行性.

研究的目的:

评估PD患者在家中进行四周间歇性缺氧治疗的安全性,耐受性和可行性.
评估这种新型治疗方法对帕金森病的净症状影响.
探索通过血生物标志物诱导神经保护途径.

主要方法:

这是一项双臂,双盲,随机对照试验,涉及40名患有轻度至中度PD的参与者.
参与者接受了45分钟的诺莫巴里克间歇性缺氧 (FiO2 0.16) 治疗,每周三次,持续四周.
同一级终点包括不良事件和可行性-耐受性问卷;二级终点包括MDS-UPDRS得分,步态和生物标志物.

主要成果:

该研究目前正在招募,结果正在等待.
分析将重点关注不良事件发生率和参与者报告的可行性和耐受性.
二次结果措施将包括MDS-UPDRS得分,步态参数和特定的等离子体生物标志物的变化.

结论:

这项试验扩展了之前的发现,调查了对帕金森病的家庭间歇性缺氧.
预计结果将提供有关该干预措施安全性和有效性的关键数据.
这项研究可能为基于缺氧的疗法铺平道路,作为PD的新治疗策略.

关键词:

疾病的修饰疾病的修饰疾病修饰性 tria 疾病修饰性 tria 氧气过低是因为缺氧.线粒体功能障碍线粒体功能障碍氧化应激是一种氧化应激.帕金森病的疾病.缺氧条件的缺氧条件

更多相关视频

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Delivery of In Vivo Acute Intermittent Hypoxia in Neonatal Rodents to Prime Subventricular Zone-derived Neural Progenitor Cell Cultures

Published on: November 2, 2015

A Model to Simulate Clinically Relevant Hypoxia in Humans

A Model to Simulate Clinically Relevant Hypoxia in Humans

Published on: December 22, 2016

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Physiological Control of Respiration

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...